As shown in Figure 6A, the MEF2D expression was significantly lower in triple-negative breast cancer (TNBC) cells compared with normal (MCF10A) or estrogen-receptor-positive (ER+) breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.